Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
1996 5
1997 1
1998 6
1999 3
2000 3
2001 2
2002 5
2003 8
2004 6
2005 8
2006 7
2007 11
2008 9
2009 3
2010 5
2011 3
2012 6
2013 4
2014 1
2015 3
2017 3
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18577560

99 results

Results by year

Filters applied: . Clear all
Page 1
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Reardon DA, Quinn JA, Rich JN, Desjardins A, Vredenburgh J, Gururangan S, Sathornsumetee S, Badruddoja M, McLendon R, Provenzale J, Herndon JE 2nd, Dowell JM, Burkart JL, Newton HB, Friedman AH, Friedman HS. Reardon DA, et al. Cancer. 2005 Oct 1;104(7):1478-86. doi: 10.1002/cncr.21316. Cancer. 2005. PMID: 16088964 Free article. Clinical Trial.
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.
Peereboom DM, Supko JG, Carson KA, Batchelor T, Phuphanich S, Lesser G, Mikkelsen T, Fisher J, Desideri S, He X, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT) Consortium. Peereboom DM, et al. J Neurooncol. 2010 Nov;100(2):261-8. doi: 10.1007/s11060-010-0190-0. Epub 2010 May 7. J Neurooncol. 2010. PMID: 20449631 Free PMC article. Clinical Trial.
Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma.
Nabors LB, Supko JG, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Desideri S, Ye X, Wright J, Gujar S, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT) CNS Consortium. Nabors LB, et al. Neuro Oncol. 2011 Dec;13(12):1324-30. doi: 10.1093/neuonc/nor145. Epub 2011 Sep 27. Neuro Oncol. 2011. PMID: 21954442 Free PMC article. Clinical Trial.
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
Loghin ME, Prados MD, Wen P, Junck L, Lieberman F, Fine H, Fink KL, Metha M, Kuhn J, Lamborn K, Chang SM, Cloughesy T, DeAngelis LM, Robins IH, Aldape KD, Yung WK. Loghin ME, et al. Clin Cancer Res. 2007 Dec 1;13(23):7133-8. doi: 10.1158/1078-0432.CCR-07-0874. Clin Cancer Res. 2007. PMID: 18056194 Free PMC article. Clinical Trial.
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
Phuphanich S, Supko JG, Carson KA, Grossman SA, Burt Nabors L, Mikkelsen T, Lesser G, Rosenfeld S, Desideri S, Olson JJ. Phuphanich S, et al. J Neurooncol. 2010 Oct;100(1):95-103. doi: 10.1007/s11060-010-0143-7. Epub 2010 Mar 8. J Neurooncol. 2010. PMID: 20213332 Free PMC article. Clinical Trial.
99 results